Counterfeiters in Europe are displaying a fondness for mimicking high-priced Roche cancer drugs. For the second time in 5 months, authorities there have uncovered fakes, and the two cases appear not to be connected.
Authorities from 8 European Union countries, backed by Europol and Eurojust, have arrested a dozen suspects and seized more than €10 million worth of counterfeit drugs, mostly fakes of erectile dysfunction drugs that an organized crime group was selling online. The raid, announced Monday, came after an investigation that lasted nearly two years.
Researchers at the University of Michigan have developed an anti-counterfeiting technology based on clear plastic labels that reveal an image when someone breathes on them.
One of two men from Turkey that federal authorities accused of smuggling counterfeit cancer drugs to the U.S. labeled as gifts or documents has admitted he is guilty.
China has established new rules to protect its pharma supply from counterfeiting and allow for faster recalls, but the government shortened the timeframe for meeting them: forcing drumakers and contractors to scramble to catch up.
The World Health Organization says counterfeit and substandard antibiotics are getting into the global supply chain and creating resistance to treatments while fueling the emergence of so-called superbugs.
Germany is implementing a system that allows the authenticity of drugs to be checked at the pharmacy level to protect against counterfeits.
Authorities recovered drugs worth $31.4 million, arrested 237 people worldwide and were able to close down 10,603 websites over a 10-day crackdown.
The FDA more than a year ago warned cancer docs that it had discovered a counterfeit of Roche's Avastin being shipped from a supplier in New York. Now authorities have come down hard on the owners of the company, indicting them on 73 counts for selling more than $17 million worth of fake or unapproved drugs.
European authorities are warning that vials of Roche's cancer med Herceptin that were stolen in Italy are now showing up across the continent with little or none of its active ingredient.